论文部分内容阅读
目的分析强化散瞳对玻璃体视网膜手术后早期高眼压的作用效果。设计回顾性病例系列。研究对象因各种原因行玻璃体视网膜手术、并且术后第1天眼压≥30 mmHg的患者32例(34眼)。方法对上述患者使用复方托吡卡胺滴眼液连续点手术眼3次,每次间隔5分钟,用药2小时后复测眼压,并对眼压等参数行t检验,比较用药前后眼压的变化。主要指标用药前、后眼压。结果用药前患者平均眼压(37.26±6.07)mmHg,用药2小时后平均眼压(34.82±8.46)mmHg,平均眼压下降2.44mmHg,差异具有统计学意义(P=0.02)。其中20例(58.82%)眼压下降,平均眼压下降6.2 mmHg;4例(11.76%)眼压不变;10例(29.41%)眼压升高,平均眼压升高4.1 mmHg。结论玻璃体视网膜手术后眼压升高并不是停止使用散瞳剂的理由,合理使用可以使近60%的患者眼压下降。
Objective To analyze the effect of mydriasis on early intraocular hypertension after vitreoretinal surgery. Design retrospective case series. Subjects underwent vitreoretinal surgery for various reasons, and 32 patients (34 eyes) had intraocular pressure ≥30 mmHg on day one postoperatively. Methods The above patients were treated with compound tropicamide eye drops for 3 consecutive eyes, with an interval of 5 minutes. The intraocular pressure was measured after 2 hours and the IOP and other parameters were measured by t test. The intraocular pressure The change. The main indicators before treatment, after intraocular pressure. Results The average intraocular pressure (37.26 ± 6.07) mmHg before treatment, average intraocular pressure (34.82 ± 8.46) mmHg after 2 hours of treatment, and mean intraocular pressure (MEH) decreased 2.44mmHg, the difference was statistically significant (P = 0.02). Among them, intraocular pressure decreased in 20 cases (58.82%), mean intraocular pressure decreased 6.2 mmHg in 4 cases (11.76%), intraocular pressure in 10 cases (29.41%) increased, and intraocular pressure increased 4.1 mmHg in average. Conclusion Intraocular pressure elevation after vitreoretinal surgery is not the reason for stopping the use of mydriatic agents. Reasonable use can reduce the intraocular pressure in nearly 60% of patients.